LOPW
PFE icon

Live Oak Private Wealth’s Pfizer PFE Stock Holding History

Live Oak Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Sell
16,484
-910
-5% -$23.8K 0.05% 159
2026
Q1 		$488K Sell
17,394
-357
-2% -$9.51K 0.07% 137
2025
Q4 		$442K Buy
17,751
+124
+0.7% +$3.13K 0.06% 136
2025
Q3 		$449K Sell
17,627
-216,868
-92% -$5.35M 0.06% 133
2025
Q2 		$5.68M Sell
234,495
-1,566
-0.7% -$36.5K 0.85% 45
2025
Q1 		$5.98M Buy
236,061
+21,405
+10% +$560K 0.97% 42
2024
Q4 		$5.69M Sell
214,656
-4,912
-2% -$133K 0.96% 41
2024
Q3 		$6.35M Sell
219,568
-4,647
-2% -$136K 1.03% 40
2024
Q2 		$6.27M Buy
224,215
+5,181
+2% +$143K 1.08% 34
2024
Q1 		$6.08M Buy
219,034
+31,187
+17% +$865K 1.05% 40
2023
Q4 		$5.41M Buy
187,847
+9,616
+5% +$291K 1.02% 43
2023
Q3 		$5.91M Buy
178,231
+2,618
+1% +$92.6K 1.26% 37
2023
Q2 		$6.44M Buy
175,613
+5,967
+4% +$232K 1.28% 36
2023
Q1 		$6.92M Buy
169,646
+16,948
+11% +$732K 1.43% 31
2022
Q4 		$7.82M Buy
152,698
+440
+0.3% +$21.1K 1.62% 19
2022
Q3 		$6.66M Buy
152,258
+523
+0.3% +$25.4K 1.5% 21
2022
Q2 		$7.96M Buy
151,735
+1,596
+1% +$81.3K 1.67% 12
2022
Q1 		$7.77M Buy
150,139
+2,766
+2% +$144K 1.5% 17
2021
Q4 		$8.7M Sell
147,373
-8,009
-5% -$397K 1.63% 15
2021
Q3 		$6.68M Sell
155,382
-8,236
-5% -$365K 1.36% 23
2021
Q2 		$6.41M Buy
163,618
+7,519
+5% +$292K 1.41% 23
2021
Q1 		$5.66M Buy
156,099
+20,403
+15% +$724K 1.39% 27
2020
Q4 		$5M Buy
135,696
+1,876
+1% +$68.8K 1.4% 30
2020
Q3 		$4.66M Buy
133,820
+3,194
+2% +$112K 1.6% 26
2020
Q2 		$4.05M Buy
130,626
+122,535
+1,514% +$4.16M 1.47% 30
2020
Q1 		$251K Sell
8,091
-307
-4% -$10.5K 0.26% 62
2019
Q4 		$312K Buy
+8,398
New +$299K 0.3% 56

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Live Oak Private Wealth's PFE Position: Q2 2026 in Review

Live Oak Private Wealth reduced its Pfizer (PFE) stake by 5.2% in Q2 2026, selling an estimated $23.8K and leaving 16,484 shares worth $397K. The position accounts for 0.05% of the portfolio, ranked #159.

Live Oak Private Wealth first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $8.7M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Live Oak Private Wealth held 16,484 shares of Pfizer worth $397K as of Q2 2026.
  • Live Oak Private Wealth sold 910 Pfizer shares in Q2 2026, an estimated $23.8K.
  • Pfizer made up 0.05% of Live Oak Private Wealth's portfolio in Q2 2026, its #159 holding.
  • Live Oak Private Wealth first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Live Oak Private Wealth's Pfizer position peaked at $8.7M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Live Oak Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.